Independently of anti-COVID-19 IgG status, and despite that there was no significant effect of APOE-ε4 genotype in wild type allele carriers and heterozygotes in the training group in contrast to comparison group, a general improvement in MMSE total scores from baseline to endpoint was observed (Figure 2C,D). The gene discussed is APOE; the disease is COVID-19.